Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines

Table 3

Status of development of some intradermal vaccines.

Pathogen	Formulation/antigen	Indication	Clinical trial status	Clinical trial ID	Refs
Influenza virus	Split virus	Influenzas A and B	Approved	NCT01712984, NCT02563093, NCT02258334, NCT01946438	[118]
Enterotoxigenic E. coli	dmLT	Gastroenteritis	Phase 1	NCT02531685	[119]
HBV	HBsAg	Hepatitis B	Phase 1	NCT02186977	[120]
Dengue virus	Attenuated virus	Dengue fever	Phase 1	NCT01765426	[121]
Poliovirus	Inactivated virus	Poliomyelitis	Phase 3	NCT03239496	[122]
HIV-1	HIV-1 DNA	AIDS	Phase 2a	PACTR2010050002122368	[123]

dmLT: double mutant heat-labile enterotoxin.